Young children in Blantyre show uneven Mycobacterium tuberculosis exposure across neighborhoods
A community survey in Blantyre, Malawi, found a measurable burden of Mycobacterium tuberculosis immunoreactivity in children aged 1 to 4 years, with clear clustering in poorer households and sharp variation across neighborhoods. The finding matters because immunoreactivity in this age group points to relatively recent infection, not remote exposure, and therefore reflects ongoing transmission in the community rather than historical disease patterns alone.
Out of 1,545 healthy children tested with QFT-Plus interferon-gamma release assay, 102 had a positive result. The prevalence was 6.6%, translating to an annual risk of Mtb infection of 2.7% with a 95% credible interval of 2.2% to 3.2%.
Recent infection, not just background exposure
The biologic logic is straightforward. In young children, a positive IGRA is a signal that transmission is still active enough to reach the household, street, or neighborhood level within a short time frame. TB surveillance often leans on case notifications, but notifications depend on who reaches care, who is tested, and who is visible to the health system. That leaves a gap when disease is concentrated in families and places least likely to appear in routine reporting.
This survey approached the problem from two directions at once: clinic-based convenience sampling and random household sampling guided by satellite imagery. That mixed design was not cosmetic. It was built to reach children who might never show up in passive surveillance streams and to map infection patterns across 33 high-burden neighborhoods in one urban setting.
Poverty tracked with infection risk
Household wealth separated the risk signal. Children from the poorest third of households had higher immunoreactivity than those from the richest third, with prevalence of 8.7% versus 4.9% and an adjusted odds ratio of 1.88, with a 95% credible interval of 1.08 to 3.01. In practical terms, the assay was not simply capturing a diffuse background of exposure across the city. It was detecting an inequitable pattern tied to deprivation.
TB spreads through social contact, crowded housing, and repeated exposure to untreated infectious disease. Poverty increases the odds of all three. It can also delay diagnosis, reduce access to care, and concentrate children in environments where transmission chains persist longer than they should. The data fit that model closely.
One result was especially stark: the positive association with household poverty did not appear to be explained by reported household TB exposure, HIV exposure, or malnutrition. The absence of those associations does not erase their importance in TB epidemiology. It suggests instead that the survey was measuring a broader transmission ecology than households can report on their own. In urban TB, the source of infection may sit outside the home as often as inside it.
Neighborhood-level variation was wide
Variation across neighborhoods was large enough to matter for program design. The estimated annual risk of Mtb infection ranged from 1.1% to 4.1% between neighborhoods. For a public health program trying to place limited resources where they will have the most effect, that spread is more than a statistical detail. It suggests that transmission is not evenly distributed across Blantyre and that a citywide average would blur important local differences.
Even more striking, neighborhood-level TB case notifications did not correlate with annual risk of infection. Routine notification data therefore failed to identify the same places that the immunoreactivity survey identified as high-risk. Case counts may still capture service use and diagnosed disease, but they do not necessarily mirror where transmission is most intense.
That gap has direct operational consequences. A district can show apparently acceptable notification patterns while children in specific neighborhoods continue to acquire infection at a substantial rate. For elimination efforts, the mismatch between notifications and true transmission pressure can leave hidden reservoirs untouched.
Why immunoreactivity surveillance may add value
Interferon-gamma release assays are not a replacement for clinical diagnosis of active TB. They do not identify who has pulmonary disease, who is infectious today, or who needs immediate treatment for illness. Their value here lies elsewhere: they offer an indirect readout of recent exposure in children too young to have accumulated decades of contact history.
That makes the survey method appealing for settings where disease prevalence surveys are increasingly expensive and passive surveillance is distorted by unequal access to care. In a declining epidemic, the signal becomes harder to find by counting cases alone. Infection-based surveillance shifts attention toward where transmission is still happening and where intervention may still prevent future disease.
The strategy also has a preventive upside. Young children are at high risk of progressing from infection to severe disease, and they are more likely than older groups to benefit from TB preventive treatment. A surveillance system that can identify the neighborhoods and households where exposure is concentrated could support better targeting of preventive therapy, contact investigation, and community outreach.
A public health map of who is still being reached by transmission
The survey’s central message is not that TB has disappeared in urban Malawi. It is that transmission persists unevenly, with the heaviest burden falling on children in poorer households and on particular neighborhoods. The biologic readout came from the children themselves, not from clinic attendance or from reported exposure histories.
That makes the findings especially relevant for program planners. If notifications are used alone, the areas with the highest transmission pressure may remain partially invisible. If immunoreactivity surveys are added to the surveillance toolkit, TB programs may gain a sharper map of where infection is still occurring and where elimination efforts need to be intensified.
The study also leaves a hard practical question in place: how best to scale this type of surveillance without losing the neighborhood-level resolution that made it useful in the first place. The methods were intentionally pragmatic, but the real test is whether similar approaches can be repeated often enough, cheaply enough, and with enough local precision to change TB control decisions on the ground.